Navigation Links
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections
Date:11/24/2008

--PS-Targeting AntibodiesMay Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections--

--Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models--

--Data Confirms PS is a 'Druggable' Target Common to a Number of Serious Viral Infections--

TUSTIN, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million with the bioterrorism program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections.

"Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new class of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center and a scientific advisor to Peregrine. "By targeting a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to treat a range of viral infections, and they should be less susceptible to the viral mutations that contribute to the development of drug resistance."

In the research reported today, scientists at UT Southwestern assessed the activity of bavituximab in animal
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
2. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
3. Results From Pre-Election Surveys Published in NEJM Show Deep Concerns About State of Health Care With McCain and Obama Supporters Differing Sharply on Directions for New Administration
4. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
5. International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer
6. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
7. McCulley/Cuppan Consultants Contribute Chapter to the Newly Published Book, Rhetoric of Healthcare: Essays Toward a New Disciplinary Inquiry
8. Notice of Proposed Rulemaking on U.S. Department of Labors Risk Assessment Procedures Published in Federal Register
9. Positive Findings Published on Emergent Technology for Treating Chronic Pain
10. Study Published in JAMA on RFID Interference Ignores Real-World Use Cases, According to SkyeTek
11. Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... It’s hard to imagine what it’s like to ... around the world, it’s a reality. And while new shoes ... forced to walk barefoot on rocky terrain or sewage-lined streets ... their friends. , Buckner International's Shoes for Orphan ... in October to encourage support for Air1 and while also ...
(Date:10/20/2014)... Maryland, USA (PRWEB) October 20, 2014 ... to track interventions? Here comes a wonderful app Metassessor ... mobile app development company helped its client “Intervention ... more efficiently. The app is designed for iOS 4.3 ... iPod touch. This app is optimized for iPhone 5. ...
(Date:10/19/2014)... October 20, 2014 Recently, BambooIndustry.com, one ... unveiled its new range of bamboo deckings . ... these natural items; they are now available at deeply ... people, it is hard to overstate the significance of ... attention to online services. The company’s workers are striving ...
(Date:10/19/2014)... 20, 2014 Having been working in the ... knowledge of customer needs. According to James, one of the ... dazzling sequins, or with high-low skirts that add beauty to ... demand. Recently, LunaDress has unveiled its new selection of 2014 ... the company’s brand new items are available in over 20 ...
(Date:10/19/2014)... a professional company of women’s dresses and related accessories, ... dresses . All the company’s old and new client ... up to 66 percent off. , SweetDressy.com is ... Its dress specialists are striving to make more trendy ... world. All the company’s items are unique, graceful and ...
Breaking Medicine News(10 mins):Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... a national leader in accounts receivable management, and collection services to ... created position of Chief Operating Officer (COO). , ... ... leader, MDS ( www.meddatsys.com ), has announced Eugene (Gene) Schneider to ...
... cause irreversible damage, doctors say , , WEDNESDAY, March 18 (HealthDay ... death Wednesday of actress Natasha Richardson, reports that she suffered ... Canadian ski slope on Tuesday have many people wondering how ... of the most lauded acting families in Great Britain; her ...
... "The White House made the correct decision ... Veterans Affairs to have military veterans, personal insurance ... said VAdm. Norb Ryan, Jr., USN-Ret., president of ... said he advised President Obama that "pursuing this ...
... cents donated for every person that playsPHOENIX, March 18 ... home products, is kicking off The Candle Game to benefit ... the free online game, Gold Canyon will donate 10 cents ... Game can be played online at http://thecandlegame.com and ...
... was 98% for Kit-positive GIST patients taking Gleevec vs. ... patients experienced recurrence of GIST(2) within a median of ... treatment in the US and Switzerland indicated to reduce ... is underway in the EU(4) EAST HANOVER, N.J., March ...
... March 18 Speaker Nancy Pelosi announced this afternoon ... that could have forced veterans to use their private insurance ... Pelosi made the announcement at a meeting she and House ... veterans, service organizations, who greeted the news with a standing ...
Cached Medicine News:Health News:Medical Data Systems, Inc. (MDS) Announces New Chief Operating Officer (COO) 2Health News:Medical Data Systems, Inc. (MDS) Announces New Chief Operating Officer (COO) 3Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 2Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 3Health News:White House Makes Correct Decision On Veterans Insurance Proposal 2Health News:Gold Canyon Ignites Hope With Online Charity Candle Game 2Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 2Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 3Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 4Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 5Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 6Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 7Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 8Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 9Health News:Pelosi: Administration Will Not Force Veterans to Use Private Insurance to Pay for Treatment of Combat-Related Injuries 2
(Date:10/19/2014)... MELVILLE, N.Y. , Oct. 19, 2014  Henry ... largest provider of health care products and services to ... that it has invested in Iwase Dental Supply, Inc., ... equipment in Japan.  The transaction marks Henry Schein,s entrance into ... largest dental market, and increases to 28 the ...
(Date:10/17/2014)... HILL, N.C. , Oct. 17, 2014 /PRNewswire/ ... landscape, the Medical Affairs function has come across ... allocating resources efficiently and managing globalization.  ... Best Practices, LLC is dedicated to providing benchmarking ... The Medical Affairs Consortium is a service composed ...
(Date:10/17/2014)... 17, 2014  Amgen (NASDAQ: AMGN ) ... , M.D., president of Gladstone Institutes and Gladstone,s Robert ... "We are pleased to welcome Dr. Sandy ... A. Bradway , chairman and chief executive officer of ... medicine and his direct experience in our industry will ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5Early Key Findings from the Medical Affairs Consortium Research 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3
... Inc . (NYSE: CRY ), a leading tissue ... surgery, announced today its results for the third quarter and ... increased 4 percent to a record $29.7 million compared to ... the first nine months increased 2 percent to a record ...
... 2011 The Breast journal published new ... National University College of Medicine in Korea that shows ... tumor detection compared to whole-body PET/CT when using both ... particularly striking and significant for smaller-sized tumors (less than ...
Cached Medicine Technology:CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 2CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 3CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 4CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 5CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 6CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 7CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 8CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 9CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 10CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 11CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 12CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 13CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 14CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 15CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 16CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 17Published Data Demonstrates Positron Emission Mammography Has Higher Sensitivity Than PET/CT 2
... is enzyme immunoassay kit for the ... concentration in serum. Enzyme immunoassay (EIA) ... many protein hormones in body fluids ... rapid and specific assay. This enzyme ...
SHIONORIA BNP,is a reagent used in the measurement of blood BNP. The blood BNP test allows accurate estimation of coronary functions....
... immunosorbent assay method for the semi-quantitative ... myeloperoxidase in human serum. The results ... used as an aid in the ... conditions associated with elevated anti-neutrophil cytoplasmic ...
... Ang II is a helpful ... effect and efficiency of a ... enzyme inhibitors (ACE Inhibitors) or ... well as for the efficiency ...
Medicine Products: